These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4943090)

  • 1. Verbal communication with L-dopa treatment.
    Yaryura-Tobias JA; Diamond B; Merlis S
    Nature; 1971 Nov; 234(5326):224-5. PubMed ID: 4943090
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamines and memory: enhanced verbal learning during L-DOPA administration.
    Murphy DL; Henry GM
    Psychopharmacologia; 1972; 27(4):319-26. PubMed ID: 4648617
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of L-dopa on neuroleptic-induced catalepsy.
    Maj J; Kapturkiewicz Z; Sarnek J
    J Pharm Pharmacol; 1972 Sep; 24(9):735-7. PubMed ID: 4404079
    [No Abstract]   [Full Text] [Related]  

  • 4. Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.
    Yang Z; Wang X; Yang J; Sun M; Wang Y; Wang X
    Neurotox Res; 2017 Apr; 31(3):334-347. PubMed ID: 27981510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopa in Parkinson's disease.
    Crawford JP
    Lancet; 1969 May; 1(7602):984. PubMed ID: 4180829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison between the effect of L-dopa and its methylated ester on cerebral dopamine and noradrenaline of rats exposed to oxypertin].
    Van den Driessche J; Sado M; Linée P; Lacroix P; Le Clec'h G; Delamaire J; Patay M
    C R Seances Soc Biol Fil; 1973; 167(5):754-9. PubMed ID: 4799139
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of neuroleptics, midantan and DOPA on apomorphine sterotypy in rats].
    Kalinin VV
    Farmakol Toksikol; 1977; 40(1):16-9. PubMed ID: 558110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the verbal interactions in a group of healthy subjects under the influence of psychological drugs].
    Battegay R; Abt K; Bogdan-Pataki N; Burger H; Spiegel R
    Schweiz Arch Neurol Neurochir Psychiatr; 1974; 114(2):339-50. PubMed ID: 4608896
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 10. An ultrastructural study of dense-cored vesicles of glomus caroticum from rats treated with L-3, 4-dihydroxyphenylalanine (L-DOPA).
    Hellström S
    Acta Physiol Pol; 1973; 24(1):225-32. PubMed ID: 4716342
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of L-dopa (L-dihydroxyphenylalanine) to stimulate ovulation.
    Benjamin F; Kolodny HD
    Am J Obstet Gynecol; 1973 Aug; 116(7):1013-6. PubMed ID: 4736952
    [No Abstract]   [Full Text] [Related]  

  • 12. Clorazepate dipotassium, tranxene: anti-anxiety and antidepressant activity.
    Plotnikoff NP
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):128-34. PubMed ID: 4631197
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Effect of acute and chronic treatment with L-dopa on catecholamine turnover.
    Yamanaka Y; Kono S
    Jpn J Pharmacol; 1974; 24(0):s:24. PubMed ID: 4545736
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
    Wajsbort J; Hemli JA; Alfandary I; Yahel M; Siegfried J
    Wien Med Wochenschr; 1971 Oct; 121(42):741-5. PubMed ID: 5115985
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of the life-span in mice adapted to large amounts of L-dopa.
    Cotzias GC; Miller ST; Nicholson AR; Maston WH; Tang LC
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2466-9. PubMed ID: 4526220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
    Donnelly EF; Chase TN
    Dis Nerv Syst; 1973 Feb; 34(2):119-23. PubMed ID: 4706860
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of affective states and psychoactive drugs on verbal learning and memory.
    Henry GM; Weingartner H; Murphy DL
    Am J Psychiatry; 1973 Sep; 130(9):966-71. PubMed ID: 4727774
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
    Giuffrè R; Gambacorta D
    Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.